This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Neuroprotective Agents

Edited by Edited by William Slikker, Jr. (National Center for Toxicological Research/FDA, Jefferson, Arkansas), Russell J. Andrews (NASA Ames Research Center, Moffett Field, California), and Bruce Trembly (Veterans Affairs Medical Center, Togus, Maine)
Neuroprotective Agents

Published: December 2007

Volume 1122

Learn More

Topics covered in this volume of the proceedings of the Eighth International Neuroprotection Society Meeting include the following clinical implications of neuroprotection (e.g., intensive care and comorbidities; anesthesia hazards) opportunities for neuroprotection; resistance to cell death; nanotechnology; neuroprotection in spinal cord injury; and global brain injury.